Bill Tracker
Legislative Session Report
The FPA works with the advocacy team at Ronald L. Book, P.A. to advance our legislative agenda and the proactive policies presented by the Government Affairs Committee (GAC). At the conclusion of each Florida legislative session, we produce a report detailing and clarifying the intricacies of each of the bills on our legislative agenda (supported, opposed, and monitoring) and how the profession will be impacted. The Legislative Session Report is a summary of the accomplishments of not only the FPA, but all members and providers in the State that have dedicated their time, resources, and efforts to keep the profession of pharmacy moving forward.
The next Florida Legislative Session will be for 60 days in 2027 from 03.02.27 until 04.30.27.
2026 Bill Tracker
Our Governmental Affair Committee (GAC) and Association Lobbying team at Ronald L. Book, P.A. are continuously monitoring and discussing the newly introduced legislation, and they are keeping an ear to the ground for potential bills that may impact the profession of pharmacy or the practice of healthcare in the State.
To view the full scope of each Bill and the actions taken click HERE
Actively Monitoring:
| HB 0029 | Sale and Purchase of Ivermectin | |||||
| Sale and Purchase of Ivermectin: Authorizes sale & purchase of specified ivermectin as over-the-counter medication without prescription or consultation with health care provider. Effective Date: July 1, 2026 | ||||||
| SB 0040 | Medicaid Providers | |||||
| Requiring the Agency for Health Care Administration to include specified requirements in its contracts with Medicaid managed care plans; defining the term “outside of regular business hours”, etc. Effective Date: July 1, 2026 | ||||||
| SB 0070 | Step-therapy Protocols | |||||
| Step-therapy Protocols; Requiring the Agency for Health Care Administration to approve drug products for Medicaid recipients for the treatment of serious mental illness without step-therapy prior authorization under certain circumstances; directing the agency to include rate impacts resulting from the act in certain rates that become effective on a specified date, etc. Effective Date: Except as otherwise expressly provided in this act and except for this section, which shall take effect upon this act becoming a law, this act shall take effect October 1, 2026 | ||||||
| SB 0138 | Advanced Practice Registered Nurse Autonomous Practice | |||||
| Advanced Practice Registered Nurse Autonomous Practice; Authorizing certain advanced practice registered nurses to engage in autonomous practice to provide mental health services as defined by rule of the Board of Nursing, etc. Effective Date: 7/1/2026 | ||||||
| HB 0163 | Access to Medicaid Providers | |||||
| Access to Medicaid Providers: Requires AHCA to include specified requirements in its contracts with Medicaid managed care plans; defines “outside of regular business hours.” Effective Date: July 1, 2026 | ||||||
| 10/14/25 HOUSE Filed | ||||||
| 10/21/25 HOUSE Referred to Health Care Facilities & Systems Subcommittee; Health Care Budget Subcommittee; Health & Human Services Committee | ||||||
| 10/21/25 HOUSE Now in Health Care Facilities & Systems Subcommittee | ||||||
| HB 0221 | Minimum Wage Requirements | |||||
| Minimum Wage Requirements: Provides that employer is not subject to state minimum wage requirements for specified employees; prohibits certain work-based learning opportunities from lasting longer than specified amount of time; authorizes employees to voluntarily opt out of state minimum wage requirements by signing waiver; prohibits employer from coercing employee into opting out of state minimum wage; provides requirements in order for waiver to be effective for minor employee; requires employers to pay employee at or above federal minimum wage; provides that employee’s waiver to opt out of state minimum wage is only valid for specified timeframe. Effective Date: July 1, 2026 | ||||||
| SB 0222 | Cost-sharing Requirements for Diabetes Management | |||||
| Cost-sharing Requirements for Diabetes Management; Prohibiting health insurance policies from imposing a cost-sharing requirement exceeding a certain amount for a 30-day supply of insulin or any diabetes device or diabetic ketoacidosis device, etc. Effective Date: 7/1/2026 | ||||||
| SB 0230 | Transparency in Insurance Matters | |||||
| Transparency in Insurance Matters; Defining the term “trade secret”; revising the requirements of a notice of trade secret submitted to the Office of Insurance Regulation or the Department of Financial Services; specifying that certain information is not a trade secret and is subject to public disclosure; requiring the office to review all claims of trade secret protection; requiring that fees, commissions, and profit-sharing agreements between insurers and affiliates be filed with the office and made publicly accessible on the department’s website, etc. Effective Date: July 1, 2026 | ||||||
| SB 0234 | Insurers’ Financial Transactions | |||||
| Insurers’ Financial Transactions; Requiring certain insurers to annually provide specified information to the Office of Insurance Regulation; requiring the office to contract annually with a specified entity to conduct a review of certain transactions; prohibiting an insurer from engaging in certain transactions with affiliates; prohibiting an insurer from declaring or paying dividends to shareholders or issuing executive bonuses under certain circumstances, etc. Effective Date: 7/1/2026 | ||||||
| HB 0293 | Continuous Glucose Monitors | |||||
| Continuous Glucose Monitors: Requires AHCA to, within specified timeframe, seek federal approval as needed to provide coverage of continuous glucose monitors & related supplies as durable medical equipment benefit under Medicaid program; provides for reimbursement of such equipment; provides construction; requires agency to implement these changes upon receiving any necessary federal approval. Effective Date: upon becoming a law | ||||||
| SB 0294 | Connecting to Care Act | |||||
| Connecting to Care Act; Citing this act as the “Connecting to Care Act”; authorizing a pharmacist to administer certain medications under certain circumstances, etc. Effective Date: July 1, 2026 | ||||||
| HB 0301 | Advanced Practice Registered Nurse Autonomous Practice | |||||
| Advanced Practice Registered Nurse Autonomous Practice: Authorizes certain advanced practice registered nurses to engage in autonomous practice to provide mental health services. Effective Date: July 1, 2026 | ||||||
| HB 0309 | Controlled Substances | |||||
| Controlled Substances: Adds to list of Schedule I controlled substances 7-Hydroxymitragynine concentrated at above 400 parts per million on dry-weight basis; excepts from list of Schedule I controlled substances certain xylazine animal drug products approved by USDA & used for certain purposes; provides criminal penalties & requires mandatory minimum term of imprisonment if person sells, manufactures, or delivers or possesses with intent to sell, manufacture, or deliver xylazine; creates offense of trafficking in xylazine; provides criminal penalties & requires mandatory minimum terms of imprisonment & mandatory fines for specified offenses involving xylazine. Effective Date: October 1, 2026 | ||||||
| HB 0339 | Advertisement of a Harmful Vaccine | |||||
| Advertisement of a Harmful Vaccine: Provides manufacturer liability; authorizes individual to file cause of action; provides that prevailing party is entitled to actual damages, court costs, & reasonable attorney fees. Effective Date: July 1, 2026 | ||||||
| HB 0367 | Cost-sharing Requirements for Insulin and Diabetes Supplies | |||||
| Cost-sharing Requirements for Insulin and Diabetes Supplies: Prohibits health insurance policies from imposing cost-sharing requirements that exceed specified amount for 30 days of insulin & diabetes supplies. Effective Date: July 1, 2026 | ||||||
| SB 0374 | Prescribing Authority | |||||
| Prescribing Authority; Deleting the requirement that a supervising physician notify the Department of Health in writing of any delegation of prescribing authority to a physician assistant; deleting the requirement that a supervising physician’s name be included in the prescription issued by a physician assistant; revising requirements for the drug formulary for physician assistants; revising the drug formulary requirements for advanced practice registered nurses authorized to prescribe medications, etc. Effective Date: 7/1/2026 | ||||||
| HB 0375 | Autonomous Practice by a Certified Registered Nurse Anesthetist | |||||
| Autonomous Practice by a Certified Registered Nurse Anesthetist: Revises staff membership & clinical privileges for certain certified registered nurse anesthetists; authorizes certain certified registered nurse anesthetists to perform specified acts; revises practice requirements for autonomous advanced practice registered nurses; authorizes autonomous advanced practice registered nurses to perform certain acts. Effective Date: July 1, 2026 | ||||||
| HB 0407 | Administration of Medications | |||||
| Administration of Medications: Authorizes pharmacist to administer certain medications. Effective Date: July 1, 2026 | ||||||
| SB 0408 | Advertisement of a Harmful Vaccine | |||||
| Advertisement of a Harmful Vaccine; Defining the term “advertise”; providing manufacturer liability under certain circumstances; authorizing an individual to file a cause of action under certain circumstances within a specified timeframe, etc. Effective Date: 7/1/2026 | ||||||
| SB 0432 | Controlled Substances | |||||
| Controlled Substances; Adding 7-Hydroxymitragynine as a Schedule I controlled substance; excepting from the list of Schedule I controlled substances certain xylazine animal drug products approved by the United States Food and Drug Administration and used for certain purposes; providing criminal penalties and requiring a mandatory minimum term of imprisonment if a person sells, manufactures, or delivers or possesses with intent to sell, manufacture, or deliver xylazine; creating the offense of trafficking in xylazine; providing criminal penalties and requiring a mandatory minimum term of imprisonment and fines based on the quantity of the controlled substance involved in the offense, etc. Effective Date: Except as otherwise expressly provided in this act and except for this section, which shall take effect July 1, 2026, this act shall take effect October 1, 2026 | ||||||
| SB 0462 | Autonomous Practice by a Certified Registered Nurse Anesthetist | |||||
| Autonomous Practice by a Certified Registered Nurse Anesthetist; Revising requirements for clinical privileges for certain certified registered nurse anesthetists; authorizing certain certified registered nurse anesthetists to perform specified acts under certain circumstances; authorizing certain autonomous advanced practice registered nurses to perform specified acts as part of their autonomous practice, etc. Effective Date: 7/1/2026 | ||||||